A wide range of calming products are marketed for anxious dogs. Understanding the evidence base helps owners make informed decisions and avoid ineffective or harmful approaches.
Anxiety significantly impairs dog welfare, and the difficulty of treating anxiety creates a market for products that may offer false hope or delay effective intervention. Dogs with significant anxiety benefit most from evidence-based behavioral modification combined with veterinary-prescribed pharmaceuticals when needed. Calming products may provide modest supplementary benefit but are often marketed with claims that exceed the evidence. The welfare risk of relying solely on commercial calming products is that genuinely anxious dogs continue suffering while owners delay seeking professional behavioral or veterinary help.